Trial Profile
Phase II Trial of Bevacizumab in Combination with XELOX in Colorectal Cancer Patients with Liver Metastases (H2, H3)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 03 Feb 2019 Status changed from active, no longer recruiting to completed.
- 15 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 23 Dec 2009 New trial record